Candel Therapeutics (CADL) Free Cash Flow: 2020-2024
Historic Free Cash Flow for Candel Therapeutics (CADL) over the last 5 years, with Dec 2024 value amounting to -$27.0 million.
- Candel Therapeutics' Free Cash Flow fell 4.30% to -$7.5 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$34.7 million, marking a year-over-year decrease of 6.07%. This contributed to the annual value of -$27.0 million for FY2024, which is 22.08% up from last year.
- Per Candel Therapeutics' latest filing, its Free Cash Flow stood at -$27.0 million for FY2024, which was up 22.08% from -$34.7 million recorded in FY2023.
- Candel Therapeutics' Free Cash Flow's 5-year high stood at -$10.5 million during FY2020, with a 5-year trough of -$34.7 million in FY2023.
- For the 3-year period, Candel Therapeutics' Free Cash Flow averaged around -$31.5 million, with its median value being -$32.7 million (2022).
- In the last 5 years, Candel Therapeutics' Free Cash Flow plummeted by 128.06% in 2021 and then climbed by 22.08% in 2024.
- Over the past 5 years, Candel Therapeutics' Free Cash Flow (Yearly) stood at -$10.5 million in 2020, then plummeted by 128.06% to -$24.1 million in 2021, then crashed by 36.02% to -$32.7 million in 2022, then decreased by 6.07% to -$34.7 million in 2023, then grew by 22.08% to -$27.0 million in 2024.